• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-A
Device Problems Calcified (1077); Device Stenosis (4066)
Patient Problem Dyspnea (1816)
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that on (b)(6) 2022, a 23mm trifecta valve was successfully implanted.On an unknown date, exercise-related shortness of breath and stenosis of the native aortic valve was noted.The patient was admitted due to stenosis of the anterior ramus interventricularis and carotistenose.Echocardiogram showed the following eoa: 0,6 cm2 (420mtr/sec).On (b)(6) 2022 the device was explanted and a non-abbott device was implanted.Upon explant, the valve was heavily calcified; no tears were observed but the valve was noted as "stiff".The patient was reported to be in stable condition.
 
Manufacturer Narrative
Explant due to stenosis of the valve was reported.The investigation found that all three leaflets contained calcifications, which limited the leaflet mobility.There was circumferential fibrous pannus ingrowth on the inflow surface of the valve.A tear was found in leaflet 2 which was associated with a calcification.There was a thin layer of fibrin on the outflow surface at the base of leaflet 1.No acute inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The calcifications and pannus noted on the valve could have contributed to the reported stenosis.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15959967
MDR Text Key305268880
Report Number2135147-2022-02493
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/18/2017
Device Model NumberTF-A
Device Catalogue NumberTF-23A
Device Lot Number4973877
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/23/2022
Initial Date FDA Received12/12/2022
Supplement Dates Manufacturer Received02/23/2023
Supplement Dates FDA Received03/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/20/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexFemale
Patient RaceWhite
-
-